Irish researchers use AI to discover many women with breast cancer could avoid chemotherapy

'For patients with an intermediate genomic risk, the decision around chemotherapy is often difficult. And uncertainty frequently leads to treatment that may not have been necessary, impacting on quality of life.'

'For patients with an intermediate genomic risk, the decision around chemotherapy is often difficult. And uncertainty frequently leads to treatment that may not have been necessary, impacting on quality of life.'

Many women with a common type of breast cancer could safely avoid chemotherapy thanks to a discovery by Irish researchers using AI.

About 70% of breast cancer diagnoses are of early-stage ER+HER2- breast cancer, and chemotherapy is regularly used to treat it.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited